Eotaxin and RANTES Expression by the Dermal Endothelium Is Associated with Eosinophil Infiltration after Ivermectin Treatment of Onchocerciasis

This publication has 35 references indexed in Scilit:

• Clinical Responses in Human Onchocerciasis: Parasitological and Immunological Implications
  Published by Wiley ,2007
• Eosinophil Sequestration and Activation Are Associated with the Onset and Severity of Systemic Adverse Reactions following the Treatment of Onchocerciasis with Ivermectin
  The Journal of Infectious Diseases, 1999
• Circulating, but not local lung, IL-5 is required for the development of antigen-induced airways eosinophilia.
  Journal of Clinical Investigation, 1998
• Enhanced expression of eotaxin and CCR3 mRNA and protein in atopic asthma. Association with airway hyperresponsiveness and predominant co‐localization of eotaxin mRNA to bronchial epithelial and endothelial cells
  European Journal of Immunology, 1997
• Observations on the formation of new onchocercal nodules in Ecuador
  Pathogens and Global Health, 1997
• Targeted Disruption of the Chemokine Eotaxin Partially Reduces Antigen-induced Tissue Eosinophilia
  The Journal of Experimental Medicine, 1997
• Cloning of the human eosinophil chemoattractant, eotaxin. Expression, receptor binding, and functional properties suggest a mechanism for the selective recruitment of eosinophils.
  Journal of Clinical Investigation, 1996
• The kinetics of allergen-induced transcription of messenger RNA for monocyte chemotactic protein-3 and RANTES in the skin of human atopic subjects: relationship to eosinophil, T cell, and macrophage recruitment.
  The Journal of Experimental Medicine, 1995
• Production of the RANTES chemokine in delayed-type hypersensitivity reactions: involvement of macrophages and endothelial cells.
  The Journal of Experimental Medicine, 1994
• Polymerase Chain Reaction-Based Diagnosis of Onchocerca volvulus Infection: Improved Detection of Patients with Onchocerciasis
  The Journal of Infectious Diseases, 1994